Painless acute pancreatitis associated with sorafenib treatment: a case report.
Kobayashi
Yasuyuki
Y
Department of Urology, Sumitomo Hospital, Kita-ku, Osaka, 530-0005, Japan. yasukoba1216@gmail.com
Kanemitu
Toshiyuki
T
Kamoto
Akihito
A
Satoh
Mototaka
M
Mori
Naoki
N
Sekii
Kenichiro
K
Yoshioka
Toshiaki
T
Itatani
Hiroaki
H
Fujimoto
Takashi
T
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000009:adverse effects* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010195:Pancreatitis / Q000139:chemically induced*; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D000077157:Sorafenib
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D007155:Immunologic Factors; D016898:Interferon-alpha; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib